liver international : official journal of the international association for the study of the liver2018Vol. 38pp. -
237
t2018liversofosbuvir/velpatasvir
Abstract
Sofosbuvir plus velpatasvir is highly effective and safe for treating patients with hepatitis C virus genotypes 1, 2, 3, 4, 5 or 6 and advanced fibrosis or compensated cirrhosis.